MARKET

QGEN

QGEN

Qiagen
NYSE
40.85
+0.26
+0.64%
Opening 14:05 11/28 EST
OPEN
40.61
PREV CLOSE
40.59
HIGH
40.90
LOW
40.43
VOLUME
515.00K
TURNOVER
0
52 WEEK HIGH
51.18
52 WEEK LOW
34.74
MARKET CAP
9.32B
P/E (TTM)
28.32
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at QGEN last week (1120-1124)?
Weekly Report · 1d ago
The one-year loss for Qiagen (NYSE:QGEN) shareholders likely driven by its shrinking earnings
Qiagen n.v. Share price slid 17% over twelve months. The stock fell 14% over the last three years, but is up 8.7% in the last 12 months. Qiagen's share price is well below the market return of 14%.
Simply Wall St · 5d ago
Weekly Report: what happened at QGEN last week (1113-1117)?
Weekly Report · 11/20 09:26
QIAGEN (QGEN) Expands Sample Technologies Line With New Launch
NASDAQ · 11/16 14:58
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Gain Therapeutics (GANX)
TipRanks · 11/15 17:10
QIAGEN (QGEN) Launches QIAcuity Kits and Software Update
NASDAQ · 11/15 11:32
Weekly Report: what happened at QGEN last week (1106-1110)?
Weekly Report · 11/13 09:24
QIAGEN Launches New QIAcuity Digital PCR Kits And Updated Software To Expand Use By Biopharma And Food Safety Customers
Qiagen announces launch of three new digital pcr kits for use on its qiacuity systems. Qiagen also plans to launch a major new software update in november. The new kits expand the portfolio of applications for digital pcr technology in areas like cell and gene therapies, dna and rna quantification and food and pharmaceuticals safety.
Benzinga · 11/09 22:31
More
About QGEN
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Webull offers Qiagen NV stock information, including NYSE: QGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QGEN stock methods without spending real money on the virtual paper trading platform.